Nucleotide substitution: C?T.
Amino acid replacement: Q468term.
C15663585T
C?T
Q134term | fus-PA; Q134term | fus-PB; Q468term | fus-PC; Q468term | fus-PD; Q468term | fus-PE; Q468term | fus-PF; Q468term | fus-PG; Q134term | fus-PH
Q468term
fus1/fus[+] is an enhancer of lethal | maternal effect phenotype of cactE10
fus1 has embryonic epidermis phenotype, non-enhanceable by Egfrt1
fus1 has embryonic epidermis phenotype, non-enhanceable by grk6
fus1 has embryonic epidermis phenotype, non-enhanceable by sqdunspecified
fus1 has embryonic epidermis phenotype, non-enhanceable by grk3
fus1/fus[+] is an enhancer of embryonic epidermis phenotype of cactE10
fus1 is an enhancer of embryonic epidermis phenotype of cactE10
More than 80% of embryos produced by cactE10/+, fus1/+ are distinctly dorsalized, and the Egfrfus,fus2 chromosome has a similar but stronger effect. Fewer than 10% of embryos produced by cactE10/+, fus1/+ females hatch and 80-90% show the twisted body and head defects characteristic of a loss of mesoderm. Mesodermal cell types are lost.
The lethality and the enhancing phenotype were not separated in 258 opportunities for recombination.